TY - JOUR AU - Jankovic, J. PY - 2008 DA - 2008// TI - Parkinson’s disease: clinical features and diagnosis JO - J Neurol Neurosurg Psychiatry VL - 79 UR - https://doi.org/10.1136/jnnp.2007.131045 DO - 10.1136/jnnp.2007.131045 ID - Jankovic2008 ER - TY - STD TI - Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, Pike B, et al. Mutation in the alpha-synuclein gene identified in families with Parkinson’s disease. Science. 1997;276:2045–7. ID - ref2 ER - TY - JOUR AU - Hardy, J. PY - 2010 DA - 2010// TI - Genetic analysis of pathways to Parkinson disease JO - Neuron VL - 68 UR - https://doi.org/10.1016/j.neuron.2010.10.014 DO - 10.1016/j.neuron.2010.10.014 ID - Hardy2010 ER - TY - JOUR AU - Sharma, J. C. AU - Vassallo, M. PY - 2014 DA - 2014// TI - Prognostic significance of weight changes in Parkinson’s disease: the Park-weight phenotype JO - Neurodegener Dis Manag VL - 4 UR - https://doi.org/10.2217/nmt.14.25 DO - 10.2217/nmt.14.25 ID - Sharma2014 ER - TY - JOUR AU - Fiala, O. AU - Zahorakova, D. AU - Pospisilova, L. AU - Kucerova, J. AU - Matejckova, M. AU - Martasek, P. PY - 2014 DA - 2014// TI - Parkin (PARK 2) mutations are rare in Czech patients with early-onset Parkinson’s disease JO - PLoS One VL - 9 UR - https://doi.org/10.1371/journal.pone.0107585 DO - 10.1371/journal.pone.0107585 ID - Fiala2014 ER - TY - JOUR AU - Moller, H. AU - Mellemkjaer, L. AU - McLaughlin, J. K. AU - Olsen, J. H. PY - 1995 DA - 1995// TI - Occurrence of different cancers in patients with Parkinson’s disease JO - BMJ VL - 310 UR - https://doi.org/10.1136/bmj.310.6993.1500 DO - 10.1136/bmj.310.6993.1500 ID - Moller1995 ER - TY - JOUR AU - Minami, Y. AU - Yamamoto, R. AU - Nishikouri, M. AU - Fukao, A. AU - Hisamichi, S. PY - 2000 DA - 2000// TI - Mortality and cancer incidence in patients with Parkinson’s disease JO - J Neurol VL - 247 UR - https://doi.org/10.1007/s004150070171 DO - 10.1007/s004150070171 ID - Minami2000 ER - TY - JOUR AU - Olsen, J. H. AU - Friis, S. AU - Frederiksen, K. AU - Mellemkjaer, L. AU - Møller, H. PY - 2005 DA - 2005// TI - Atypical cancer pattern in patients with Parkinson’s disease JO - Br J Cancer VL - 92 UR - https://doi.org/10.1038/sj.bjc.6602279 DO - 10.1038/sj.bjc.6602279 ID - Olsen2005 ER - TY - JOUR AU - Elbaz, A. AU - Peterson, B. J. AU - Bower, J. H. AU - Yang, P. AU - Maraganore, D. M. AU - McDonnell, S. K. PY - 2005 DA - 2005// TI - Risk of cancer after the diagnosis of Parkinson’s disease: a historical cohort study JO - Mov Disord VL - 20 UR - https://doi.org/10.1002/mds.20401 DO - 10.1002/mds.20401 ID - Elbaz2005 ER - TY - JOUR AU - Lo, R. Y. AU - Tanner, C. M. AU - Eeden, S. K. AU - Albers, K. B. AU - Leimpeter, A. D. AU - Nelson, L. M. PY - 2010 DA - 2010// TI - Comorbid cancer in Parkinson’s disease JO - Mov Disord VL - 25 UR - https://doi.org/10.1002/mds.23246 DO - 10.1002/mds.23246 ID - Lo2010 ER - TY - JOUR AU - O’Flanagan, C. H. AU - Morais, V. A. AU - Wurst, W. AU - De Strooper, B. AU - O'Neill, C. PY - 2015 DA - 2015// TI - The Parkinson’s gene PINK1 regulates cell cycle progression and promotes cancer-associated phenotypes JO - Oncogene VL - 34 UR - https://doi.org/10.1038/onc.2014.81 DO - 10.1038/onc.2014.81 ID - O’Flanagan2015 ER - TY - JOUR AU - Cao, J. AU - Lou, S. AU - Ying, M. AU - Yang, B. PY - 2015 DA - 2015// TI - DJ-1 as a human oncogene and potential therapeutic target JO - Biochem Pharmacol VL - 93 UR - https://doi.org/10.1016/j.bcp.2014.11.012 DO - 10.1016/j.bcp.2014.11.012 ID - Cao2015 ER - TY - JOUR AU - Cordeiro, Y. AU - Foguel, D. AU - Silva, J. L. PY - 2013 DA - 2013// TI - Pressure-temperature folding landscape in proteins involved in neurodegenerative diseases and cancer JO - Biophys Chem VL - 183 UR - https://doi.org/10.1016/j.bpc.2013.06.002 DO - 10.1016/j.bpc.2013.06.002 ID - Cordeiro2013 ER - TY - JOUR AU - Kawashima, M. AU - Suzuki, S. O. AU - Doh-ura, K. AU - Iwaki, T. PY - 2000 DA - 2000// TI - Alpha-synuclein is expressed in a variety of brain tumors showing neuronal differentiation JO - Acta Neuropathol VL - 99 UR - https://doi.org/10.1007/PL00007419 DO - 10.1007/PL00007419 ID - Kawashima2000 ER - TY - JOUR AU - Matsuo, Y. AU - Kamitani, T. PY - 2010 DA - 2010// TI - Parkinson’s disease-related protein, alpha-synuclein, in malignant melanoma JO - PLoS One VL - 5 UR - https://doi.org/10.1371/journal.pone.0010481 DO - 10.1371/journal.pone.0010481 ID - Matsuo2010 ER - TY - JOUR AU - Bruening, W. AU - Giasson, B. I. AU - Klein-Szanto, A. J. AU - Lee, V. M. AU - Trojanowski, J. Q. AU - Godwin, A. K. PY - 2000 DA - 2000// TI - Synucleins are expressed in the majority of breast and ovarian carcinomas and in preneoplastic lesions of the ovary JO - Cancer VL - 88 UR - https://doi.org/3.0.CO;2-9 DO - 3.0.CO;2-9 ID - Bruening2000 ER - TY - JOUR AU - Hod, Y. PY - 2004 DA - 2004// TI - Differential control of apoptosis by DJ-1 in prostate benign and cancer cells JO - J Cell Biochem VL - 92 UR - https://doi.org/10.1002/jcb.20159 DO - 10.1002/jcb.20159 ID - Hod2004 ER - TY - JOUR AU - MacKeigan, J. P. AU - Clements, C. M. AU - Lich, J. D. AU - Pope, R. M. AU - Hod, Y. AU - Ting, J. P. PY - 2003 DA - 2003// TI - Proteomic profiling drug-induced apoptosis in non-small cell lung carcinoma: identification of RS/DJ-1 and RhoGDIalpha JO - Cancer Res VL - 63 ID - MacKeigan2003 ER - TY - JOUR AU - Devine, M. J. AU - Plun-Favreau, H. AU - Wood, N. W. PY - 2011 DA - 2011// TI - Parkinson’s disease and cancer: two wars, one front JO - Nat Rev Cancer VL - 11 UR - https://doi.org/10.1038/nrc3150 DO - 10.1038/nrc3150 ID - Devine2011 ER - TY - JOUR AU - Kennedy, C. H. AU - Pass, H. I. AU - Mitchell, J. B. PY - 2003 DA - 2003// TI - Expression of human MutT homologue (hMTH1) protein in primary non-small-cell lung carcinomas and histologically normal surrounding tissue JO - Free Radic Biol Med VL - 34 UR - https://doi.org/10.1016/S0891-5849(03)00176-X DO - 10.1016/S0891-5849(03)00176-X ID - Kennedy2003 ER - TY - STD TI - Laman H, Funes JM, Ye H, Galinanes-Garcia L, Hara E, Knowles P. Transforming activity of Fbxo7 is mediated specifically through regulation of cyclin D/cdk6. EMBO J. 2005;24:3104–16. ID - ref21 ER - TY - JOUR AU - DOSHAY, L. J. PY - 1954 DA - 1954// TI - Problem situations in the treatment of paralysis agitans JO - J Am Med Assoc VL - 156 UR - https://doi.org/10.1001/jama.1954.02950070008003 DO - 10.1001/jama.1954.02950070008003 ID - DOSHAY1954 ER - TY - JOUR AU - WARBURG, O. PY - 1956 DA - 1956// TI - On the origin of cancer cells JO - Science VL - 123 UR - https://doi.org/10.1126/science.123.3191.309 DO - 10.1126/science.123.3191.309 ID - WARBURG1956 ER - TY - STD TI - Iyer AM, van Scheppingen J, Milenkovic I, Anink JJ, Adle-Biassette H, Kovacs GG. mTOR hyperactivation in down syndrome hippocampus appears early during development. J Neuropathol Exp Neurol. 2014;73:671–83. ID - ref24 ER - TY - JOUR AU - Heras-Sandoval, D. AU - Perez-Rojas, J. M. AU - Hernandez-Damian, J. AU - Pedraza-Chaverri, J. PY - 2014 DA - 2014// TI - The role of PI3K/AKT/mTOR pathway in the modulation of autophagy and the clearance of protein aggregates in neurodegeneration JO - Cell Signal VL - 26 UR - https://doi.org/10.1016/j.cellsig.2014.08.019 DO - 10.1016/j.cellsig.2014.08.019 ID - Heras-Sandoval2014 ER - TY - JOUR AU - O’ Neill, C. PY - 2013 DA - 2013// TI - PI3-kinase/Akt/mTOR signaling: impaired on/off switches in aging, cognitive decline and Alzheimer’s disease JO - Exp Gerontol VL - 48 UR - https://doi.org/10.1016/j.exger.2013.02.025 DO - 10.1016/j.exger.2013.02.025 ID - O’ Neill2013 ER - TY - JOUR AU - Liu, P. AU - Cheng, H. AU - Roberts, T. M. AU - Zhao, J. J. PY - 2009 DA - 2009// TI - Targeting the phosphoinositide 3-kinase pathway in cancer JO - Nat Rev Drug Discov VL - 8 UR - https://doi.org/10.1038/nrd2926 DO - 10.1038/nrd2926 ID - Liu2009 ER - TY - STD TI - Chia S, Gandhi S, Joy AA, Edwards S, Gorr M, Hopkins S. Novel agents and associated toxicities of inhibitors of the pi3k/Akt/mtor pathway for the treatment of breast cancer. Curr Oncol. 2015;22:33–48. ID - ref28 ER - TY - STD TI - Safdari Y, Khalili M, Ebrahimzadeh MA, Yazdani Y, Farajnia S. Natural inhibitors of PI3K/AKT signaling in breast cancer: emphasis on newly-discovered molecular mechanisms of action. Pharmacol Res. 2015;93:1–10. ID - ref29 ER - TY - JOUR AU - Hanahan, D. AU - Weinberg, R. A. PY - 2011 DA - 2011// TI - Hallmarks of cancer: the next generation JO - Cell VL - 144 UR - https://doi.org/10.1016/j.cell.2011.02.013 DO - 10.1016/j.cell.2011.02.013 ID - Hanahan2011 ER - TY - JOUR AU - Velayati, A. AU - Yu, W. H. AU - Sidransky, E. PY - 2010 DA - 2010// TI - The role of glucocerebrosidase mutations in Parkinson disease and Lewy body disorders JO - Curr Neurol Neurosci Rep VL - 10 UR - https://doi.org/10.1007/s11910-010-0102-x DO - 10.1007/s11910-010-0102-x ID - Velayati2010 ER -